← Leaderboards
Klara O Felsovalyi
Genecentrix, Inc.
$807,763
Attributed
$807,763
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.8K · FY2015–16$500K$375K$250K$125K$0
'15
'16
Funding mix
By agency
NIH$807,763 · 1
By mechanism
R43$807,763 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Compounding”
- Leonard Freedman · Leidos Biomedical Research, Inc.$235,521,096
- David Heimbrook · Leidos Biomedical Research, Inc.$137,012,890
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- John Damon Chodera · Sloan-Kettering Inst Can Research$55,754,876
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Drug CompoundingAffinityAlgorithmsBiologyCatalogingBaseBiological MarkersCollectionComplexComputer AnalysisComputing MethodologiesCostCost EffectiveCatalogsClinical PhenotypeDatabasesData SetDetectionDisease PhenotypeDockingDrug ApprovalDrug CandidateDrug CombinationsDrug Development
Grant awards (4)
Novel tool for linking drugs and phenotypes$405,083
R43 · FY2016 · GM · contact PI
Novel tool for linking drugs to phenotypes - I-Corps Supplement$40,000
R43 · FY2016 · GM · contact PI
Crowdsourcing Phenotypes - Diversity Supplement$12,680
R43 · FY2016 · GM · contact PI
Novel tool for linking drugs and phenotypes$350,000
R43 · FY2015 · GM · contact PI